|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/451 | |
| A61K 31/58 | |||
| A61K 9/00 | |||
| A61K 9/10 | |||
| A61K 47/38 | |||
| A61K 47/26 | |||
| A61P 11/02 | |||
| A61P 27/14 |
| (11) | Number of the document | 2931249 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13803046.5 |
| Date of filing the European patent application | 2013-12-13 | |
| (97) | Date of publication of the European application | 2015-10-21 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/076486 |
| Date | 2013-12-13 |
| (87) | Number | WO 2014/095602 |
| Date | 2014-06-26 |
| (30) | Number | Date | Country code |
| 201261737927 P | 2012-12-17 | US | |
| 201361867794 P | 2013-08-20 | US |
| (72) |
IGNAR, Diane Michele, US
LEVIN, Daren Scott, US
|
| (73) |
Glaxo Group Limited,
980 Great West Road Brentford, Middlesex TW8 9GS,
GB
|
| (54) | COMBINATION OF LEVOCABASTINE AND FLUTICASONE FUROATE FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC CONDITIONS |
| COMBINATION OF LEVOCABASTINE AND FLUTICASONE FUROATE FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC CONDITIONS |